Ben Green1, Tor Pettit, Lesley Faith
1Cheadle Royal Hospital, Department of Psychiatry, University of Liverpool, UK. bgreen@affinityhealth.co.uk
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Levomepromazine is a useful psychiatric medication for schizophrenia and schizoaffective disorder, especially in intensive care due to its sedative effects. Further research is needed for its efficacy in drug-resistant psychosis.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: